British Journal of Cancer - 

Tumour-agnostic drugs in paediatric cancers

British Journal of Cancer, Published online: 12 March 2020; doi:10.1038/s41416-020-0770-5Tumour-agnostic drugs in paediatric cancers

British Journal of Cancer - Issue - nature.com science feeds

3h

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

British Journal of Cancer, Published online: 12 March 2020; doi:10.1038/s41416-020-0774-1Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

British Journal of Cancer - Issue - nature.com science feeds

3h

Tumour-agnostic drugs in paediatric cancers

British Journal of Cancer - Issue - nature.com science feeds

6h

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

British Journal of Cancer - Issue - nature.com science feeds

6h

Mark above section as read